Urovant Sciences

Urovant Sciences

World Rank (Jan-05-2024)

11,036

World Rank (Jul-30-2023)

11,036

World Rank (Jan-07-2022)

11,036

World Rank (Jan-01-2021)

11,036

Market Cap (Jan-01-2021)

0.512 Billion USD

Headquarters Country

World Region

World Subregion

Northern America

Business Sector

Biopharmaceutical

Company Website

UROVANT SCIENCES

Company Profile

Urovant Sciences is a Biopharmaceutical company focused on developing and commercializing innovative therapies for a range of urologic conditions. The company estimated annual revenue is currently 39.2 million USD per year. The headquarters is in USA.

Stock Exchange

Share